The objective of this project (2) is to characterize essential correlates of chlamydial infection of the human reproductive tract in the human reproductive tract. This will prime effective translational research through the identification and characterization of chlamydial antigens of relevance to vaccine development and of physiologic or pathogenetic mechanisms that are at play in the complex, natural environment of the female genital tract and provide targets for possible chemotherapeutic intervention. The project involves extensive collaboration with the complementary projects 1 and 3 of the CRC and will rely on Cores B, C and D for the provision of guinea pig and human sera and swabs, and biostatistical analysis of the results, respectively. In a first phase, the virulence of C. trachomatis and C. caviae genital isolates will be quantified in relationship to genome sequence type and reproductive tract ecology using a patient cohort representative of genital chlamydial disease in humans. Virulence will be measured using genomic doubling, infectious yield, inclusion fusogenicity and pathology as measurable physiological/pathogenic traits or endpoints, and using biomathematical modeling of Intracellular development and correlated pathology. A second phase of the research will be to investigate in relationship to genome sequence type and reproductive tract ecology the functional diversity of two gene families of C. trachomatis and C. caviae encoding inclusion membrane proteins (Inc) and effector proteins of the virulence-associated type III secretion (T3S) system that are targets for possible chemotherapeutic intervention. The developmental expression of selected inc and T3S effector genes in variants of C. trachomatis and C. caviae will be characterized and subcellular and molecular targets of variant Inc and T3S effector proteins will be identified. Finally, the diversity of the vaccine target pmp gene family and Pmp-specific antibody responses in C trachomatis -infected patients and C. caviae-infected guinea pigs will be investigated in relationship to genome sequence type and reproductive tract ecology. This will be achieved through characterization of the developmental expression of pmp genes in variants of C. trachomatis and C. caviae, profiling the high frequency on/off switching of Pmp expression in selected variants and performing cross-sectional and longitudinal investigations of the Pmp-specific antibody response comparatively in infected humans and guinea pigs.
Chlamydial infection are a major health risk to young sexually active women and can results in serious conditions such as pelvic inflammatory disease (PID) a cause of infertility in women. Studies on Chlamydial infections have focused on the pathogen itself. It is becoming increasingly evident that the microbes that inhabit the vagina play a critical protective role. We will examine how the vaginal microbiota reacts to Chlamydial infections and treatments in order to provide a new view of the infectious process.
|Mendes-Soares, Helena; Suzuki, Haruo; Hickey, Roxana J et al. (2014) Comparative functional genomics of Lactobacillus spp. reveals possible mechanisms for specialization of vaginal lactobacilli to their environment. J Bacteriol 196:1458-70|
|Bavoil, Patrik M (2014) What's in a word: the use, misuse, and abuse of the word "persistence" in Chlamydia biology. Front Cell Infect Microbiol 4:27|
|Bavoil, Patrik M; Byrne, Gerald I (2014) Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease). Pathog Dis 71:287-91|
|Hickey, Roxana J; Forney, Larry J (2014) Gardnerella vaginalis does not always cause bacterial vaginosis. J Infect Dis 210:1682-3|
|Adams, Nancy E; Thiaville, Jennifer J; Proestos, James et al. (2014) Promiscuous and adaptable enzymes fill "holes" in the tetrahydrofolate pathway in Chlamydia species. MBio 5:e01378-14|
|Brotman, Rebecca M; Ravel, Jacques; Bavoil, Patrik M et al. (2014) Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. Vaccine 32:1543-52|
|Hovis, Kelley M; Mojica, Sergio; McDermott, Jason E et al. (2013) Genus-optimized strategy for the identification of chlamydial type III secretion substrates. Pathog Dis 69:213-22|
|Vorimore, Fabien; Hsia, Ru-Ching; Huot-Creasy, Heather et al. (2013) Isolation of a New Chlamydia species from the Feral Sacred Ibis (Threskiornis aethiopicus): Chlamydia ibidis. PLoS One 8:e74823|
|Yeruva, Laxmi; Spencer, Nicole; Bowlin, Anne K et al. (2013) Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis 68:88-95|
|Fisher, Derek J; Fernández, Reinaldo E; Maurelli, Anthony T (2013) Chlamydia trachomatis transports NAD via the Npt1 ATP/ADP translocase. J Bacteriol 195:3381-6|
Showing the most recent 10 out of 14 publications